Kiryluk Lab

About CureGN

The CureGN Study is a longitudinal multicenter cohort study of glomerular disease patients funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health (NIH). The CureGN project aims to recruit and follow 2,400 children and adults with minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), membranous nephropathy (MN), and IgA nephropathy (IgAN). Participants will be followed longitudinally to better understand the causes of disease, response to therapy, and disease progression, with the ultimate objective of finding a cure for glomerulonephropathy. Columbia University is one of the four participating clinical centers. The network supports multidisciplinary collaborative research, early phase testing of novel therapies, and effective public-private-patient advocate partnerships

For more information, please visit curegn.org and our brochure.